These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7408948)

  • 1. Selective inhibition of mesolimbic behavioral supersensitivity by naloxone.
    Seeger TF; Nazzaro JM; Gardner EL
    Eur J Pharmacol; 1980 Aug; 65(4):435-8. PubMed ID: 7408948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects.
    Borowski TB; Kokkinidis L
    Pharmacol Biochem Behav; 1992 Sep; 43(1):1-15. PubMed ID: 1409792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds.
    Nazzaro JM; Seeger TF; Gardner EL
    Pharmacol Biochem Behav; 1981 Mar; 14(3):325-31. PubMed ID: 7232458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of footshock stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine.
    Kamata K; Yoshida S; Kameyama T
    Brain Res; 1986 Apr; 371(1):197-200. PubMed ID: 3011201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.
    Stinus L; Winnock M; Kelley AE
    Psychopharmacology (Berl); 1985; 85(3):323-8. PubMed ID: 2860688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in mesolimbic electrical self-stimulation after chronic haloperidol: reversal by L-DOPA or lithium.
    Seeger TF; Gardner EL; Bridger WF
    Brain Res; 1981 Jun; 215(1-2):404-9. PubMed ID: 6790126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antagonism by naloxone of inhibitory effects of haloperidol and morphine on brain self-stimulation.
    Wauquier A; Niemegeers CJ; Lal H
    Psychopharmacologia; 1974; 37(4):303-10. PubMed ID: 4859277
    [No Abstract]   [Full Text] [Related]  

  • 9. Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold.
    Seeger TF; Carlson KR; Nazzaro JM
    Pharmacol Biochem Behav; 1981 Oct; 15(4):583-6. PubMed ID: 7291262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.
    van Wolfswinkel L; van Ree JM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):84-92. PubMed ID: 4047179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased mesolimbic dopamine binding following chronic haloperidol treatment.
    Kamer RS; Turi AR; Solomon PR; Kaplan LJ
    Psychopharmacology (Berl); 1981; 72(3):261-3. PubMed ID: 6784143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of dopaminergic mesolimbic receptor supersensitivity by haloperidol.
    Davis KL; Hollister LE; Fritz WC
    Life Sci; 1978 Oct; 23(15):1543-8. PubMed ID: 723433
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity.
    Seeger TF; Gardner EL
    Brain Res; 1979 Oct; 175(1):49-57. PubMed ID: 114275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat.
    Pei Q; Zetterström T; Leslie RA; Grahame-Smith DG
    Eur J Pharmacol; 1993 Jan; 230(1):63-8. PubMed ID: 8381355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
    Ahtee L; Kaakkola S
    Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of the endorphinergic and dopaminergic modulation on the immobility reflex elicited by clamping in rats.
    de la Cruz F; Russek M; Junquera J
    Int J Psychophysiol; 1990 Sep; 9(2):171-7. PubMed ID: 2228751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-neuroleptic interaction in brainstem self-stimulation.
    Rompré PP; Wise RA
    Brain Res; 1989 Jan; 477(1-2):144-51. PubMed ID: 2702479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide-dopamine interactions. III. Cyclo(His-Pro) and persistence of dopaminergic supersensitivity on withdrawal from one year continuous neuroleptic treatment.
    Prasad C
    Schizophr Res; 1988; 1(6):411-5. PubMed ID: 2908706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward.
    van Wolfswinkel L; Seifert WF; van Ree JM
    Pharmacol Biochem Behav; 1988 Jul; 30(3):589-95. PubMed ID: 3211968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.